Skip to main content
. 2016 Sep 11;24(e1):e121–e128. doi: 10.1093/jamia/ocw123

Box 1:

Purpose and benefits of disease registries

Quality improvement
  • Identifying gaps in care (HbA1c not checked)

  • Identifying care goals not obtained (HbA1c > 8%, BP > 140/90 mmHg, etc.)

  • Identifying medications not used (statins, ACEi/ARB)

Understanding the burden of disease and complications
  • Comprehending disease disparities

  • Finding undiagnosed cases

Identifying patients for research projects
Comparing care quality across sites
Comparing complexity of patients across sites
Comparative effectiveness research
Epidemiologic surveillance, including longitudinal analyses
Population-based care management studies of people with diabetes

ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BP, blood pressure; HbA1c, glycated hemoglobin.